Implanon: a review of the literature with recommendations for clinical management.
Implanon is a new implantable, progestin-only contraceptive which was approved in the United States in July 2006. Implanon is comprised of a single ethylene vinylacetate copolymer rod that is 4 cm long and 2 mm in diameter. It is inserted subdermally in the groove between the biceps and triceps of the nondominant arm. A literature review was conducted and side effects are discussed. Implanon offers promise as a high-efficacy, long-term contraceptive and can enhance the contraceptive options offered by the women's health care providers. Clinical trial data indicate that the device is both safe and effective.
Adams
Kate
K
kate.adams@aya.yale.edu
Beal
Margaret W
MW
D003271:Contraceptive Agents, Female / Q000009:adverse effects / Q000494:pharmacology; D017135:Desogestrel / Q000009:adverse effects / Q000494:pharmacology; D004343:Drug Implants; D005260:Female; D006801:Humans; D008599:Menstruation Disturbances / Q000139:chemically induced; D014481:United States
D003271:Contraceptive Agents, Female; D004343:Drug Implants; C044815:etonogestrel; D017135:Desogestrel